The demand for Hepatitis E diagnostic tests in the United States is gradually increasing as awareness of viral hepatitis expands and diagnostic capabilities improve across healthcare systems Hepatitis E virus HEV though historically associated with developing regions is now increasingly …

Hepatitis E virus (HEV) infection is a frequent cause of acute viral hepatitis. Immunocompromised patients, especially those under anti-CD20 regimens, are prone to chronic or treatment-resistant cour…

Every year there are an estimated 20 million hepatitis E infections, over 3 million symptomatic cases of hepatitis E, and 56 600 hepatitis E-related deaths.

Within the hepatitis E virus (HEV) ORF1 polyprotein, the X domain interacts with viral RNA-dependent RNA polymerase (RdRp), forming a functional “pocket-like” cavity (PC) that is crucial for viral re…

Scientists at the University Medical Center Hamburg-Eppendorf (UKE) have examined pig slurry from the northwestern region of Germany and detected

Hepatitis A is a viral liver disease that can cause mild to severe illness.

In recent news, Atea Pharmaceuticals reported ongoing progress in its global Phase 3 hepatitis C program and unveiled a new hepatitis E drug initiative targeting immunocompromised patients, with updated clinical data highlighting a potential best-in-class therapy from its bemnifosbuvir and ruzasvir combination. The announcement also featured new insights into the drugs’ dual mechanism of action, […]

In a groundbreaking study published in npj Viruses, researchers have unveiled critical insights into the mechanisms regulating the internal ribosome entry site (IRES)-like element activity of genotype one hepatitis E virus (HEV). The investigation elucidates how viral proteins

npj Viruses – Viral helicase and methyltransferase promote genotype one-hepatitis e virus internal ribosome entry site-like element activity

PDF | The pathogenic mechanisms determining the diverse clinical outcomes of HEV infection (e.g., self-limiting versus chronic or symptomatic versus… | Find, read and cite all the research you need on ResearchGate

BackgroundHepatitis E virus (HEV) is a major global public-health threat. University students are at high risk of HEV infection. This study aimed to assess t…

Hepatitis E Diagnostic Tests Market is expected to reach USD 97.3 million and likely to surge at a CAGR of 5.0% during forecast period from 2025 to 2035.

Hepatitis A virus (HAV) infection in adults is usually self-limited, yet atypical extrahepatic features may complicate the course. We report a 20-year-old male with fever, jaundice, and moderate…

Nature Biomedical Engineering – A modular nanobody-based approach assembles combination vaccines by stably attaching diverse antigens to hepatitis E virus-like particles, preserving native…

Introduction Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis in South Asia, frequently causing waterborne outbreaks. Despite the recognized past and potential future epidemic burden in Nepal, data on the serological and molecular characteristics of, and co-infections with, Hepatitis A, B, and C viruses remain scarce. This study aimed to perform […]

BMC Infectious Diseases – Hepatitis E virus (HEV) is a leading cause of acute viral hepatitis in South Asia, frequently causing waterborne outbreaks. Despite the recognized past and potential…

global Hepatitis E Diagnostic Tests market size was USD 0.044 billion in 2025 and is projected to reach USD 0.053 billion by 2034, exhibiting a CAGR of 2.1%

IntroductionHepatitis E virus (HEV) is foodborne zoonotic pathogen widespread among European swine yet unstudied in Bosnia and Herzegovina (B&H). We estimate…

PDF | Hepatitis E virus (HEV) is an under-recognized cause of viral hepatitis, with rising incidence in high-income countries largely driven by zoonotic… | Find, read and cite all the research you need on ResearchGate

Hepatitis E is a preventable disease of the liver caused by the hepatitis E virus (HEV).